Hydroxychloriquine
- All
- News
-
Medical Journal Lancet Withdraws Study Flagging COVID-19 Drug's Risk
- Friday June 5, 2020
- World News | Agence France-Presse
Three of the four authors behind a large-scale study in The Lancet that raised safety fears over the use of common anti-malarial drugs to treat COVID-19 retracted their paper on Thursday, blaming a health care company that supplied the dataset.
- www.ndtv.com
-
Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment
- Sunday May 31, 2020
- Business | Reported by Sunil Prabhu, Edited by Abhik Deb
The minister said that India has been recognised as the Pharmacy of the World during the COVID-19 crisis
- www.ndtv.com/business
-
WHO Stops Trial Of Anti-Malarial Drug For COVID-19 Over Safety Concerns
- Tuesday May 26, 2020
- World News | Agence France-Presse
The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
- www.ndtv.com
-
Trump's Out-Of-The-Blue Confession: I've Been On Hydroxychloroquine
- Tuesday May 19, 2020
- World News | Agence France-Presse
President Donald Trump on Monday made the surprise announcement that he is taking hydroxychloroquine, an anti-malaria drug that his own government experts say is not suitable for fighting the novel coronavirus.
- www.ndtv.com
-
Russia Expresses Gratitude To India For Sending Medicines To Fight Virus
- Friday April 17, 2020
- World News | ANI
Russia on Friday extended its gratitude to India for sending medicines to Moscow to help it fight the coronavirus pandemic.
- www.ndtv.com
-
"Will Not Be Forgotten": Trump Thanks India For Allowing Key Drug Export
- Thursday April 9, 2020
- India News | Edited by Shylaja Varma
Extraordinary times require even closer cooperation between friends, US President Donald Trump said on Wednesday, thanking India after the government allowed the United States to buy 29 million doses of hydroxychloroquine, an anti-malarial drug believed effective in the treatment of coronavirus.
- www.ndtv.com
-
Medical Journal Lancet Withdraws Study Flagging COVID-19 Drug's Risk
- Friday June 5, 2020
- World News | Agence France-Presse
Three of the four authors behind a large-scale study in The Lancet that raised safety fears over the use of common anti-malarial drugs to treat COVID-19 retracted their paper on Thursday, blaming a health care company that supplied the dataset.
- www.ndtv.com
-
Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment
- Sunday May 31, 2020
- Business | Reported by Sunil Prabhu, Edited by Abhik Deb
The minister said that India has been recognised as the Pharmacy of the World during the COVID-19 crisis
- www.ndtv.com/business
-
WHO Stops Trial Of Anti-Malarial Drug For COVID-19 Over Safety Concerns
- Tuesday May 26, 2020
- World News | Agence France-Presse
The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
- www.ndtv.com
-
Trump's Out-Of-The-Blue Confession: I've Been On Hydroxychloroquine
- Tuesday May 19, 2020
- World News | Agence France-Presse
President Donald Trump on Monday made the surprise announcement that he is taking hydroxychloroquine, an anti-malaria drug that his own government experts say is not suitable for fighting the novel coronavirus.
- www.ndtv.com
-
Russia Expresses Gratitude To India For Sending Medicines To Fight Virus
- Friday April 17, 2020
- World News | ANI
Russia on Friday extended its gratitude to India for sending medicines to Moscow to help it fight the coronavirus pandemic.
- www.ndtv.com
-
"Will Not Be Forgotten": Trump Thanks India For Allowing Key Drug Export
- Thursday April 9, 2020
- India News | Edited by Shylaja Varma
Extraordinary times require even closer cooperation between friends, US President Donald Trump said on Wednesday, thanking India after the government allowed the United States to buy 29 million doses of hydroxychloroquine, an anti-malarial drug believed effective in the treatment of coronavirus.
- www.ndtv.com